Antisecretory Factor in Primary Glioblastoma 1

Clinical trial NCT04116138 · COMPLETED

Trial details

NCT number: NCT04116138
Sponsor: Peter Siesjö
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glioblastoma Cerebral Edema Chemotherapy Effect

Start date: 2019-09-01
Primary completion: 2021-03-31
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.